Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

NCT05732948 is registered in ClinicalTrials.gov with Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd as lead sponsor.

NCT NCT05732948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
Lead sponsor
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
August 2, 2018
Completion date
December 31, 2024
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer